NCT01457378已完成不适用
Assessment of Gastrointestinal Symptoms and Health-related Quality of Life in Healthy People and Patients With Irritable Bowel Syndrome
Danone Research2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2011年9月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
- 试验地点
- 2
研究概览
简要总结
The aim of this study performed in Irritable Bowel Syndrome (IBS) subjects and healthy patients is to demonstrate the ability of composite score of frequency of gastrointestinal symptoms to discriminate healthy subjects and IBS patients. The properties of this questionnaire of composite score of gastrointestinal symptoms frequency will be compared to other validated questionnaires (severity of IBS symptoms and HRQoL).
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •for Healthy subjects :
- •Healthy women and men free-living subject aged from 18 to 65 years.
- •Subject with a body mass index between 18 and 30, bounds included.
- •Subject having given written consent to take part in the study.
- •Chronic medical treatment-free excluding contraceptive and stable Hormonal Replacement Therapy
- •for IBS Patients :
- •IBS women and men free-living subject aged from 18 to 65 years
- •Subject with a diagnosis of IBS according to Rome III criteria: recurrent abdominal pain or discomfort at least 3 days per month in the last 3 months associated with 2 or more of the following: improvement with defecation; onset associated with a change in frequency of stool; onset associated with a change in form (appearance) of stool.
- •Subject with a diagnosis of IBS according to Rome III criteria with symptom onset at least 6 months prior to diagnosis.
- •Subject having an IBS-SSS score higher or equal to 75 corresponding to an active phase of IBS symptoms.
- •Subject having given written consent to take part in the study.
排除标准
- •for Healthy subjects :
- •Subject who, in the past, has consulted a general practitioner or a gastroenterologist for (IBS) or any other functional bowel disease including constipation and diarrhoea.
- •Subject with known organic disease, including an inflammatory bowel disease, a benign or malign tumour of intestine or colon and significant systemic disease
- •Subject treated with any chronic medical treatment that, in the investigator's opinion could interfere with the GI tract.
- •Subject who underwent general anaesthesia in the preceding 4 weeks.
- •Pregnant subject or breast-feeding subject at the time of the study.
- •Subject with known immunosuppression
- •Subject with any known food allergy
- •Subject involved in any other clinical study within the preceding month or in exclusion period after another clinical study.
- •Subject in a situation, which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject.
- •Subject not able to read, to understand and/or to answer to the questionnaires.
- •for IBS Patients :
- •If a subject fulfils with one of the following criteria, he/she must be excluded from the study:
- •Subject with a diagnosis of IBS with clinical signs of alarm (rectorragy, fever, associated inflammatory articular signs, recent weight loss).
- •Subject with known organic disease, including an inflammatory bowel disease, a benign or malign tumour of intestine or colon and significant systemic disease.
- •Subject who underwent general anaesthesia in the preceding 4 weeks.
- •Pregnant subject or breast-feeding subject at the time of the study.
- •Subject involved in any other clinical study within the preceding month or in exclusion period after another clinical study.
- •Taking antidepressant or analgesic drugs.
- •Subject not able to read, to understand and/or to answer to the questionnaires.
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Response of Irritable Bowel Syndrome to Abdominal Fat ReductionAbdominal ObesityObesityIrritable Bowel SyndromeNCT05879692Cairo University60
已完成
不适用
Tolerability and Effectiveness of Progut in Treatment of Irritable Bowel SyndromeIrritable Bowel Syndrome (IBS)NCT00904696National University Hospital, Singapore50
已完成
不适用
A Study Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS)Irritable Bowel SyndromeNCT04072991Sheffield Teaching Hospitals NHS Foundation Trust101
已完成
不适用
Evaluation Study of the Intestinal Microbiota and Quality of Life in Patients Suffering From IBS Treated With BifidiceIrritable Bowel SyndromeNCT05663060Istituto Clinico Humanitas8
已完成
不适用
Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in ChinaIrritable Bowel Syndrome (IBS)NCT02955316AstraZeneca3,000